Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
Clinical trial NCT04245397 · RECRUITING
Trial details
- NCT number
- NCT04245397
- Sponsor
- Syntrix Biosystems, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-30
- Primary completion
- 2028-03-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.